MIMS2 and cancer: Accumulating evidence has indicated that mitochondria had a central and multifunctional role in malignant tumor progression, and targeting mitochondria provides therapeutic opportunities.15 In our screen model, we demonstrated that the loss of a novel mitochondrial protein, FAM210B, was significantly associated with metastasis and decreased survival in a clinical setting.